Author

Waltraud Evers

Observed name: Evers, W.

Institution: Bruker (Germany)

Observed institution: Bruker (Germany)

OpenAlex ID: A5026196879

Correct primary structure assessment and extensive glyco-profiling of cetuximab by a combination of intact, middle-up, middle-down and bottom-up ESI and MALDI mass spectrometry techniques

2013 · Daniel Ayoub, Wolfgang Jabs, et al. · mAbs · 184

NIST Interlaboratory Study on Glycosylation Analysis of Monoclonal Antibodies: Comparison of Results from Diverse Analytical Methods

2019 · Maria Lorna A. De Leoz, David L. Duewer, et al. · Molecular & Cellular Proteomics · 120

Full validation of therapeutic antibody sequences by middle-up mass measurements and middle-down protein sequencing

2016 · Anja Resemann, Wolfgang Jabs, et al. · mAbs · 73

Use of PASEF for Accelerated Protein Sequence Confirmation and De Novo Sequencing with High Data Quality

2021 · Detlev Suckau, Waltraud Evers, et al. · Methods in molecular biology · 8

SDS-PAGE-MALDI-TDS: Mass Spectrometric Top-Down Sequencing of Proteins Extracted from Polyacrylamide Gels

2010 · Evers, W., Resemann, A., et al. · PubMed Central · 1

NIST Interlaboratory Study on GlycosylationAnalysis of Monoclonal Antibodies: Comparison ofResults from Diverse Analytical Methods

2020 · Maria Lorna A. De Leoz, David L. Duewer, et al.

Works count: 6

Citation count: 386

H-index: 4

I10-index: 3